Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologica |
Vol/bind | 53 |
Udgave nummer | 10 |
Sider (fra-til) | 2129-33 |
Antal sider | 5 |
ISSN | 1432-0428 |
DOI | |
Status | Udgivet - 1 okt. 2010 |
ID: 33901146